Executive Summary
This UPC decision addresses an application for protection of confidential information filed by Arkyne Technologies S.L. The Court of First Instance found that specific experimental data regarding Bioo Panels qualified as a trade secret under Article 58 UPCA. Access to this sensitive information was strictly restricted, creating a 'confidentiality club' limited to key personnel and legal representatives of the defendant (Plant-e). This ruling reinforces the court's power to protect proprietary business knowledge during complex litigation.
What the Court Held — Ratio Decidendi
The court ruled that the Redacted Information qualifies as confidential under Article 58 UPCA and R. 262A.1 RoP. Access was strictly limited to Plant-e's legal representatives, designated experts, and specific employees for use solely within the main infringement proceedings.
Practitioner Note
This decision granted relief to the petitioner. If you are facing a similar patent dispute before The Hague (NL) Local Division, this precedent supports interim or final relief where the facts are comparable. The ratio regarding the applied tests is particularly relevant for strategy.
Related Cases
Teleflex Life Sciences II LLCvsSpeed Care Mineral GmbH
Teleflex Life Sciences II LLC sought provisional measures against Speed Care Mineral GmbH regarding the alleged infringement of its patent on clay-based hemostatic agents. The UPC Local Division in Hamburg dismissed the application, finding that Teleflex failed to provide sufficient certainty that the Defendant's product contained a binder element as required by the patent claims. This decision highlights the high evidentiary threshold required for applicants seeking urgent relief like preliminary injunctions under the UPC framework.
Innovative Sonic CorporationvsGuangdong OPPO Mobile Telecommunications Corp. Ltd.
This UPC decision addresses a procedural application concerning the language of proceedings in an infringement case involving major mobile technology players. The Court granted the request to switch from German to English, aligning with the patent's granted language. This ruling emphasizes that fairness and the operational realities of multinational defendants—who communicate internationally in English—must be weighed heavily against local court preferences.
LiNA Medical AGvsTonglu Qianyan Medtech Co., Ltd.
LiNA Medical AG sought provisional measures at the UPC Düsseldorf Local Division to preserve evidence by inspecting a 'disposable morcellator' exhibited by Tonglu Qianyan Medtech Co., Ltd. during the MEDICA trade fair, citing suspected infringement of EP 2 593 025 B1. The Applicant argued that detailed analysis was necessary to confirm component identity and potential infringement. However, the Court ultimately rejected the application for preservation of evidence.
Sanofi-Aventis Deutschland GmbHvsAmgen, Inc.
This Court of Appeal decision addressed an application by Sanofi and Regeneron seeking suspensive effect on a ruling that rejected their request for patent revocation. The court ruled against the applicants, emphasizing that applications for rehearing do not inherently possess suspensive effect under UPC rules. The decision underscores the high threshold required to suspend proceedings based on procedural defects in the UPC.
Seoul Viosys Co., Ltd.vsPhoton Wave Co., Ltd.
This UPC decision addresses a complex application for cost reimbursement following preliminary objection proceedings regarding patent competence. Seoul Viosys sought compensation for costs incurred during the legal dispute over whether the Central or Local Division was competent to hear the revocation action. The Court ruled that while the application was admissible, the recoverable costs were limited because the preliminary objection lacked the technical depth of the main revocation action. Ultimately, a partial award of EUR 11,200 was granted.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.